Interaction Details

There were no interactions found between Lenvatinib and Lemon Verbena. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.


Still looking for more information about combining Lenvatinib and Lemon Verbena? Ask Dr. Brian Staiger about it by contacting him directly.

Lemon Verbena Overview

Lemon Verbena Lemon verbena is a small flowering shrub native to South America. Widely used in teas, beverages, foods, and perfumes, it has a history of traditional medicinal use for gastrointestinal, venous, and neurological conditions. Its leaf and flowering tops are most utilized, with water-based extracts rich in polyphenols like flavone diglucuronides and verbascoside. The essential oil contains caryophyllene, limonene, and linalool, and may possess antimicrobial properties. Lemon verbena leaf extracts are often standardized for polyphenol content, with specific products containing 18% polyphenols or 9% verbascoside and isoacteoside. Lemon verbena has a lemony fragrance and flavor but is not botanically related to lemons. Research suggests that verbascoside, found in lemon verbena, has anti-inflammatory effects, potentially impacting cytokine levels in multiple sclerosis. There's also interest in its anti-obesity effects, with studies showing potential appetite reduction and satiety promotion. Additionally, the plant's extracts may have antiparasitic effects against mites and ticks, and some studies indicate it could reduce muscle damage and oxidative stress related to exercise.
See More Information Regarding Lemon Verbena

Lenvatinib Overview

  • Lenvatinib is used to treat a certain type of thyroid cancer that has returned or that has spread to other parts of the body and cannot be treated with radioactive iodine. Lenvatinib is also used along with everolimus (Afinitor, Zortress) to treat renal cell carcinoma (RCC, a type of cancer that begins in the kidney) in people who have previously received treatment with another chemotherapy medication. Lenvatinib is also used along with pembrolizumab (Keytruda) as an initial treatment for advanced renal cell carcinoma. Lenvatinib is also used to treat hepatocellular carcinoma (HCC; a type of liver cancer) that cannot be treated with surgery. Lenvatinib is also used along with pembrolizumab (Keytruda) to treat a certain type of cancer of the endometrium (lining of the uterus) that has spread to other parts of the body or worsened during or after treatment with chemotherapy medications or that cannot be treated with surgery or radiation therapy. Lenvatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells.

See More Information Regarding Lenvatinib

Lemon Verbena - More Interactions

Lemon Verbena interacts with 22 drugs

Interaction Rating Key

These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.

Major The combined use of these agents is strongly discouraged as serious side effects or other negative outcomes could occur.
Moderate Use cautiously under the care of a healthcare professional or avoid this combination. A significant interaction or negative outcome could occur.
Minor Be aware that there is a chance of an interaction. Watch for warning signs of a potential interaction.
Unknown No interactions have been reported or no interaction data is currently available.

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.

Ask A Pharmacist About Your Herbal Questions!

Dr. Brian Staiger, PharmD

In addition to being a clinical pharmacist specializing in pharmacotherapy, Dr. Brian Staiger is a registered herbalist through the American Herbalist Guild. He has combined his passion for pharmacy practice with the study of medical ethnobotany to improve patient care. Feel free to reach out about any of your herbal or medication questions!

Ask A Pharmacist